Insider Trading & Ownership of WENDY L. DIXON

Summary: The estimated net worth of WENDY L. DIXON is at least $3,956,865 dollars as of 30 May 2025. WENDY L. DIXON is the Director of Alkermes plc. and owns shares of Alkermes plc. (ALKS) stock worth about $1.86M. WENDY L. DIXON is the Director of INCYTE CORP and owns shares of INCYTE CORP (INCY) stock worth about $1.09M. WENDY L. DIXON is the Director of IOVANCE BIOTHERAPEUTICS, INC. and owns shares of IOVANCE BIOTHERAPEUTICS, INC. (IOVA) stock worth about $468.5K. WENDY L. DIXON is the Director of ARVINAS, INC. and owns shares of ARVINAS, INC. (ARVN) stock worth about $350.5K. WENDY L. DIXON is the Director of Black Diamond Therapeutics, Inc. and owns shares of Black Diamond Therapeutics, Inc. (BDTX) stock worth about $172.8K. WENDY L. DIXON is the Director of bluebird bio, Inc. and owns shares of bluebird bio, Inc. stock worth about $17K.
Signature: /s/ Timothy J. Sangiovanni, Attorney-in-Fact for Wendy L. Dixon
All Insider Reports: All Insider Reports

Notify me when WENDY L. DIXON files a new Insider Trading report.

Ownership of WENDY L. DIXON

Symbol	Company	Relationship	Holdings Value	Report Period
ALKS	Alkermes plc.	Director	$1,855,322	14 Jun 2022
INCY	INCYTE CORP	Director	$1,092,732	31 Mar 2022
IOVA	IOVANCE BIOTHERAPEUTICS, INC.	Director	$468,517	10 Jun 2022
ARVN	ARVINAS, INC.	Director	$350,528	15 Jun 2023
BDTX	Black Diamond Therapeutics, Inc.	Director	$172,765	15 Mar 2024
BLUE	bluebird bio, Inc.	Director	$17,001	11 Nov 2021
ZVRA	ZEVRA THERAPEUTICS, INC.	Director		29 May 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.